Educational guide
Post-translational Modification
Post-translational Modification Site-Defined PTM PeptidesMulti-PTM Peptide PanelsMatched Control PeptidesPTM-Focused QC Support At Creative Peptides, we provide custom post-translational modification services for research teams that need chemically defined pep
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Post-translational Modification
Site-Defined PTM PeptidesMulti-PTM Peptide PanelsMatched Control PeptidesPTM-Focused QC Support
At Creative Peptides, we provide custom post-translational modification services for research teams that need chemically defined peptides with precise modification sites, consistent composition, and decision-ready analytical data. Our workflow supports single-site and multi-site PTM peptide preparation for phosphorylation, acetylation, methylation, glycosylation, sulfation, lipidation, and other project-relevant formats evaluated case by case. By combining peptide synthesis, peptide modification services, PTM-aware purification, and application-aligned characterization, we help biotech, pharma, academic, and assay development teams move from sequence design to assay-ready modified peptides with greater control over site, state, and comparability.
What Problems Post-Translational Modification Peptides Solve
Many PTM-related research programs stall not because the biology lacks relevance, but because the material used to study it is too variable. Native samples often contain mixed modification occupancy, overlapping proteoforms, unstable PTM states, or multiple nearby candidate sites, making it difficult to assign a clear functional readout to one defined molecular event.
Our post-translational modification service helps address these research bottlenecks by:
Separating heterogeneous signals into defined peptide states: Site-specific synthetic PTM peptides allow researchers to evaluate one modification, one site, and one stoichiometric state at a time.
Clarifying PTM crosstalk: Matched single-PTM and multi-PTM analogs make it easier to compare whether neighboring modifications act independently, cooperatively, or antagonistically.
Improving assay confidence: Modified and unmodified control peptides support kinase studies, reader-domain assays, antibody specificity checks, pull-down workflows, and LC-MS method development.
Reducing risk around labile chemistries: PTM-aware route design, purification, and handling guidance are especially useful when the project involves acid-sensitive, oxidation-prone, or otherwise fragile modifications.
Our Post-Translational Modification Services
We build PTM peptide projects around the actual scientific question rather than treating every modified sequence as a routine synthesis request. Whether you need a single phosphopeptide, a histone-inspired modification ladder, a glycopeptide standard, or a panel of matched analogs for structure-function comparison, our team can configure a practical route with the right balance of construct design, purification strategy, and analytical depth. Projects may start from a client-supplied target sequence or be integrated with our custom peptide synthesis platform for de novo construct development.
PTM Feasibility Review and Sequence Planning
Successful PTM peptide production starts with a clear design review. We assess sequence length, modification position, terminal format, residue environment, and the number of PTMs needed in the same construct before proposing a synthesis route.
Review of exact PTM site, state, and residue identity, such as pSer vs pThr, Lys(Ac) vs N-terminal acetylation, or mono-, di-, and trimethylation.
Evaluation of whether the project is best served by one target peptide, a site-isomer set, or a broader comparison panel.
Planning around peptide length, sequence hydrophobicity, acidic residue density, and purification behavior.
Recommendation of matched control peptides to strengthen downstream interpretation.
This front-end planning is particularly valuable when a project needs to isolate the effect of a single PTM variable from several plausible alternatives.
Phosphorylated and Polyphosphorylated Peptide Synthesis
Phosphorylation remains one of the most requested PTM formats for signaling, kinase, phosphatase, and reader-domain studies. We support site-defined phosphopeptide preparation from simple mono-phosphorylated constructs to more demanding multi-phosphorylated analogs.
Site-specific incorporation of phosphoserine, phosphothreonine, and phosphotyrosine residues.
Preparation of single-site, double-site, and comparative phosphorylation-state panels.
Design support for closely spaced phosphosites and sequences prone to difficult coupling or side reactions.
Parallel preparation of non-phosphorylated parent peptides or partial-site controls when interpretation requires them.
These constructs are commonly requested for enzyme assays, phospho-reader profiling, binding comparisons, and phospho-specific analytical workflows.
Acetylated and Methylated Peptide Services
Acetylation and methylation projects often require more than simply inserting one modified residue. The scientific value usually depends on whether the exact position, charge state, and methylation level are defined correctly.
N-terminal acetylated peptides and residue-specific lysine acetylation support.
Lysine and arginine methylation in defined mono-, di-, or trimethyl states as project-relevant.
Panel design for histone-inspired sequences, chromatin-associated binding studies, and enzyme-state comparison.
Matched control sets for reader, writer, or eraser assay development.
This service is especially useful when small changes in PTM state can strongly alter recognition behavior or assay output.
Glycopeptide, Sulfated, and Other Sensitive PTM Formats
Certain PTM categories place greater demands on building-block selection, protecting-group logic, purification, and post-production handling. We support defined glycopeptide and sulfated peptide projects with route selection aligned to feasibility and use case.
Planning and production support for selected glycan-bearing constructs through our glycopeptide synthesis services.
Site-defined tyrosine sulfation for receptor, chemokine, and recognition-focused studies.
PTM-sensitive purification planning for constructs that show instability, broad chromatographic peaks, or recovery challenges.
Case-by-case review of complex or combined PTM designs that need special route evaluation.
These projects benefit from early discussion of assay buffer, storage, and analytical requirements so the final construct is fit for purpose.
Multi-PTM Panels and Matched Comparison Sets
A single modified peptide is not always enough to answer the biological question. Many teams need a small, well-designed panel that compares site variants, PTM combinations, or modified versus unmodified states under the same analytical framework.
Single-PTM versus multi-PTM comparison panels for crosstalk studies.
Site-isomer sets when several nearby residues may be modified in the biological system.
Parent peptide, partially modified, and fully modified comparators for cleaner mechanistic interpretation.
Panel formats that can also support downstream peptide library and array workflows where broader interaction screening is needed.
This approach helps reduce ambiguity and gives researchers a more useful experimental set than a single isolated target.
Assay-Ready Labels, Affinity Handles, and Isotope Options
Some PTM peptide programs also require a defined detection or capture handle in addition to the biological modification itself. We can configure orthogonal add-ons without losing focus on PTM placement and interpretability.
Optional integration of stable isotope labeled peptides for mass spectrometry workflows and reference standards.
Fluorescence and dye-labeled peptide services for assay readout, binding, and localization-oriented experiments.
Biotinylated peptides or other affinity-oriented designs for pull-down and surface-binding workflows.
Spacer and handle planning to preserve PTM interpretation while enabling detection or immobilization.
The goal is to keep the PTM as the biological variable while making the peptide more usable in the intended assay system.
Purification, Characterization, and Documentation Support
PTM peptides often need more than routine purity testing. We align purification and release data with the chemistry and the way the material will be used in research.
Analytical HPLC and LC-MS confirmation of expected identity and modification-associated mass shift.
Purification strategy selection for highly acidic, hydrophobic, glycan-bearing, or closely related analog series.
Additional analytical options such as UV-based review or amino acid analysis where project design makes them useful.
Batch documentation and handling guidance tailored to PTM sensitivity and assay context.
Stronger characterization helps teams compare analogs more confidently and transfer materials into downstream workflows with less uncertainty.
Common PTM Peptide Formats and Research Uses
Different PTM classes create different synthesis and interpretation challenges. The table below summarizes the formats most frequently requested in PTM peptide projects and the practical considerations that often shape route selection.
Phosphorylation
Ser, Thr, Tyr
Kinase and phosphatase assays, signaling studies, phospho-reader profiling, LC-MS references
Closely spaced phosphosites and highly acidic sequences can complicate coupling, purification, and yield
Unmodified parent, site-isomer controls, partial phosphorylation variants
Acetylation
N-terminus, Lys side chain
Histone-related binding studies, acetyl-reader assays, enzyme-state comparison
Exact placement matters because terminal acetylation and lysine acetylation affect charge and recognition differently
Non-acetylated parent, alternate-site acetylated analogs
Methylation
Lys, Arg
Chromatin biology, reader specificity studies, enzyme assays
Mono-, di-, and trimethyl states must be explicitly distinguished during design and QC
State ladder such as Kme1, Kme2, Kme3 or matched unmethylated control
Glycosylation
Defined glycan-bearing residues, commonly Asn, Ser, or Thr depending on construct
Glycan-mediated recognition, receptor binding, antibody or lectin studies
Glycan identity, linkage, and peptide length strongly influence feasibility, purification, and analysis
Aglycone parent, alternate glycoforms, simplified glycan controls
Tyrosine Sulfation
Tyr
Receptor and chemokine binding studies, interaction mapping
Sulfate-bearing peptides require PTM-aware handling because the modification can be comparatively fragile
Non-sulfated parent, site-swap or adjacent-site controls
Lipidation
N-terminus, Cys, Lys, or linker-defined site
Membrane interaction studies, localization research, property tuning
Hydrophobicity gain may reduce solubility and complicate chromatographic recovery
Non-lipidated parent and linker-only comparator
Project Inputs, Control Strategy, and QC Planning
PTM peptide projects move more efficiently when the request defines not only the sequence, but also the exact modification state, comparison logic, and downstream use. The first table below shows the inputs that most directly affect feasibility and analytical planning.
Sequence Boundaries
Peptide length and motif context influence feasibility, folding tendency, and assay relevance
Minimal motif, flanking-sequence construct, longer epitope segment
Recommended construct length and terminal format
Exact PTM Site and State
The biological interpretation depends on site specificity and the correct modification state
pSer vs pThr, N-Ac vs Lys(Ac), Kme1 vs Kme3, defined glycoform
Site-defined synthesis map and expected mass profile
Single vs Multi-PTM Design
Complexity increases quickly when more than one modification must be installed and compared
One-site target, paired PTMs, PTM matrix or crosstalk panel
Recommended build strategy and comparator set
Terminal Format and Extra Chemistry
Termini and optional handles can alter charge, solubility, detection, and assay compatibility
Free acid, amide, N-terminal cap, spacer, biotin, fluorophore, isotope label
Final construct definition suitable for the intended workflow
Control Peptide Requirement
Modified peptides are more informative when compared against a deliberate reference set
Unmodified parent, site-isomer, partially modified, alternate-state analog
Cleaner interpretation of binding, enzyme, or analytical data
Analytical and Handling Expectations
PTM category and assay format determine what release data and storage guidance are most helpful
HPLC, LC-MS, UV review, amino acid analysis, PTM-sensitive storage notes
More useful QC package for assay transfer and internal review
In many cases, the most productive ordering strategy is to request the target PTM peptide together with a small comparison set rather than as a standalone sequence. The table below links common research goals to practical peptide-set design.
Kinase or Phosphatase Study
Phosphorylated target, unmodified parent, and nearby site-isomer controls
Enzyme turnover, binding comparison, LC-MS signal tracking
Helps separate true site preference from general sequence recognition
Reader-Domain or Chromatin Binding Assay
Acetylated or methylated target plus state ladder or alternate-site analogs
SPR, BLI, fluorescence, pull-down, competition binding
Clarifies whether recognition depends on PTM state, position, or both
PTM-Specific Antibody Validation
Modified target, non-modified parent, and neighboring-site controls
ELISA-format assays, dot blot, competitive binding, capture workflows
Reduces the risk of reporting sequence binding as PTM specificity
LC-MS / Quantitative Proteomics Support
Native PTM peptide and, where useful, isotope-labeled analog
Retention-time confirmation, transition development, peak assignment
Improves method development and comparability across runs
PTM Crosstalk Mapping
Single-PTM peptides plus multi-PTM combinations built on the same parent sequence
Binding series, enzyme-state comparison, structural or biophysical screening
Shows whether one modification enhances, masks, or redirects the effect of another
Glycopeptide or Sulfated-Peptide Recognition Study
Modified target with aglycone or non-sulfated comparator and optional glycoform variants
Receptor binding, recognition assays, analytical comparison
Helps quantify the direct contribution of the PTM to the observed signal
Why Choose Our Post-Translational Modification Platform
Site-Defined Construct Design
We organize projects around the exact PTM site, state, and comparison logic needed for interpretable data, not just around a modified sequence alone.
Support for Single and Multi-PTM Workflows
From one modified peptide to a crosstalk-focused panel, we can configure projects that compare PTM states side by side under the same analytical framework.
PTM-Aware Purification Strategy
Acidic, hydrophobic, glycan-bearing, or otherwise sensitive constructs are approached with purification logic selected for the chemistry rather than by default methods alone.
Matched Controls for Better Interpretation
We frequently recommend unmodified, alternate-site, or alternate-state controls so your final peptide set is more useful in binding, enzyme, and analytical studies.
Flexible Assay Integration
Stable isotope, fluorescence, and affinity-handle options can be added where needed to support LC-MS, capture, or readout-oriented workflows without losing PTM clarity.
Practical Documentation and Communication
Each project is planned with the downstream user in mind so the delivered material, QC package, and handling guidance support easier handoff into research workflows.
Post-Translational Modification Service Workflow
Our workflow is designed to convert a PTM question into a useful experimental peptide set with clear construct definition, relevant controls, and fit-for-purpose analytical support.
1
Sequence Intake and Scientific Scoping
We review the parent sequence, desired PTM type, exact site, target quantity, purity expectations, and intended assay or analytical use.
Where helpful, we suggest a more informative peptide set that includes the right controls rather than only the primary modified construct.
2
PTM Route Assessment and Construct Definition
Our team evaluates route feasibility based on sequence context, PTM sensitivity, peptide length, and whether the project requires one peptide or a comparative panel.
The final construct map covers modification state, termini, optional handles, and any recommended companion analogs.
3
Synthesis of Modified Peptides and Controls
The selected PTM peptides are synthesized using route conditions aligned to the chemistry and analytical requirements of the project.
When applicable, matched controls or additional PTM-state variants are prepared in parallel to improve downstream comparison.
4
Purification and Identity Confirmation
Each construct is purified with methods selected for the peptide class, especially when the project includes highly acidic, hydrophobic, or glycan-bearing sequences.
Identity and PTM installation are checked through analytical methods such as HPLC and LC-MS.
5
PTM-Focused QC Review and Handling Guidance
We prepare the agreed analytical package and flag any handling points relevant to labile or assay-sensitive PTM classes.
This step helps reduce avoidable sample loss or interpretation problems once the peptides enter the user's workflow.
6
Delivery and Follow-On Expansion
Final materials are supplied with the defined project documentation for research use.
Follow-on support may include added site-isomers, expanded PTM combinations, isotope-labeled references, or assay-oriented tagged analogs.
Research Uses of Post-Translationally Modified Peptides
PTM peptides are most valuable when a project needs a defined molecular state rather than a heterogeneous biological mixture. Below are representative research directions where post-translational modification services provide practical value.
Signaling and Enzyme-Substrate Studies
Site-defined phosphopeptides can be used in kinase and phosphatase workflows that need clear substrate identity and matched controls.
Comparative phosphorylation-state panels help distinguish true site preference from broader sequence effects.
Modified and unmodified pairs provide cleaner benchmarks for optimization of enzyme assay conditions.
Chromatin and Epigenetics Research
Acetylated and methylated peptides support reader-domain, writer, and eraser studies where PTM state determines recognition.
Histone-inspired peptide sets help compare mono-, di-, and trimethyl states or alternate acetylation patterns.
Defined comparison panels are particularly useful when multiple neighboring lysines or arginines may influence the signal.
Glycopeptide and Sulfated-Peptide Recognition Work
Glycan-bearing and sulfated peptides are used in recognition studies where the modification itself drives binding behavior.
Aglycone or non-sulfated comparators help quantify how much of the observed result comes from the PTM.
These constructs are useful when receptor or interaction mapping requires well-controlled modification presentation.
LC-MS Method Development and Quantitative Workflows
Site-defined PTM peptides support retention-time confirmation, transition selection, and peak assignment in targeted mass spectrometry.
Stable isotope-labeled references can strengthen comparison across runs and sample sets.
Well-characterized PTM standards help reduce ambiguity when endogenous signals are weak or structurally complex.
Antibody, Capture, and Binding Assay Development
PTM peptides are widely used to evaluate whether an antibody or binding reagent recognizes the modification state rather than only the surrounding sequence.
Biotinylated, fluorescent, or otherwise assay-adapted PTM peptides can support pull-down, surface-binding, and competitive assay formats.
Modified versus unmodified comparison sets improve specificity assessment during assay development and reagent screening.
FAQs
Post-translational modifications (PTMs) are chemical modifications made to a peptide or protein after its synthesis, which are essential for regulating its activity, stability, and interaction with other molecules. These modifications play a key role in biological processes like protein folding, signaling, and enzyme activity.
PTMs can alter the peptide's physicochemical properties, such as charge, hydrophobicity, and conformation. These changes can enhance or inhibit the peptide's ability to interact with target proteins or other biomolecules, thereby modulating its biological activity and specificity.
PTMs occur in various cellular compartments. For example, glycosylation happens in the endoplasmic reticulum (ER) and Golgi apparatus, phosphorylation typically occurs in the cytoplasm or nucleus, and acetylation often takes place on histones in the nucleus, influencing gene expression.
We offer a wide range of PTM services, including phosphorylation, glycosylation, acetylation, sulfation, hydroxylation, and prenylation. Each of these modifications can be performed enzymatically or chemically to meet specific research needs.
PTMs are crucial in protein engineering as they can enhance protein function, stability, and specificity. By introducing modifications like phosphorylation or acetylation, peptides can be engineered for better performance in various applications, such as proteomics, biomarker discovery, and structural studies.
Yes, we specialize in synthesizing peptides with multiple PTMs, providing flexibility in designing peptides with enhanced properties for specific research applications, such as improved binding affinity or better solubility.
Start Your Post-Translational Modification Project
If your team needs a reliable partner for phosphorylated peptides, acetylated or methylated analogs, glycopeptides, sulfated peptides, isotope-labeled PTM references, or multi-PTM comparison panels, Creative Peptides can support your project with practical route planning, PTM-aware analytics, and research-focused technical communication. Contact us today to discuss your target sequence, modification site, control strategy, and analytical requirements.